Add-on Acquisition • Information Technology

Odyssey Therapeutics Acquires Rahko

On January 6, 2022, Odyssey Therapeutics acquired information technology company Rahko

Acquisition Context

This is Odyssey Therapeutics’ 1st transaction in the Information Technology sector.
This is Odyssey Therapeutics’ 1st transaction in the United Kingdom.

Explore All 9664 Add-on Acquisition Information Technology Deals - Search the Database Free

M&A Deal Summary
Date	January 6, 2022
Target	Rahko
Sector	Information Technology
Buyer(s)	Odyssey Therapeutics
Deal Type	Add-on Acquisition

Target Company

Rahko

London, United Kingdom

Rahko is a quantum machine learning company cutting the cost and time to discover and develop new drugs. Rahko was founded in 2018 and is based in London, United Kingdom.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Odyssey Therapeutics

Boston, Massachusetts, United States

Category	Company
Founded	2021
Sector	Life Science

DESCRIPTION

Odyssey Therapeutics is a biotechnology company that develops next generation immunomodulators and oncology medicines. Odyssey Therapeutics was founded in 2021 and is based in Boston, Massachusetts.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Information Technology	1 of 1
Type: Add-on Acquisition	1 of 1
Country: United Kingdom	1 of 1
Year: 2022	1 of 1

Explore Related M&A Activity

Information Technology M&A - Add-on Acquisition M&A Deals - United Kingdom M&A - 2022 M&A